Jim Cramer's Mad Dash: How Healthy Is CVS?

NEW YORK (TheStreet) -- Shares of CVS Caremark (CVS) are muted after the company released its first-quarter earnings. Although the company beat on revenue estimates, TheStreet's Jim Cramer, co-manager of the Action Alerts PLUS portfolio, was more concerned about the company's declining same-store sales, which fell 3.8%.

"That took my breath away," he said on CNBC's "Cramer's Mad Dash" segment Friday. 

Investors have to know why same-store sales decline so much, especially since Rite-Aid (RAD), which many consider a "second-rate CVS," saw same-store sales climb 4.7%, he said. 

Rite-Aid and CVS have many similar locations, likely making some investors wonder if Rite-Aid is taking market share from CVS. 

However, don't write off CVS just yet. It's "a great company" and could be a buying opportunity, Cramer concluded. He just wants to know why same-store sales declined so meaningfully.


-- Written by Bret Kenwell in Petoskey, Mich.

At the time of publication, Cramer's Action Alerts PLUS had no position in companies mentioned.

More from Opinion

These 5 Tech Giants Still Aren't That Expensive

These 5 Tech Giants Still Aren't That Expensive

Intel CEO Brian Krzanich's Ouster Proves CEOs Aren't Above the Rules

Intel CEO Brian Krzanich's Ouster Proves CEOs Aren't Above the Rules

Red Hat CFO Tells TheStreet: Tech Trends Are Still in Our Favor

Red Hat CFO Tells TheStreet: Tech Trends Are Still in Our Favor

Throwback Thursday: Intel Edition

Throwback Thursday: Intel Edition

Intel's Next CEO Should Try Harder to Protect Its Flanks Against AMD and Others

Intel's Next CEO Should Try Harder to Protect Its Flanks Against AMD and Others